The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Panigrahi Dipak since 2010.
The trader's CIK number is 1490883.
At the time of the last reporting, Panigrahi Dipak was the SVP, R&D and CMO of Novelion Therapeutics Inc.. (stock ticker symbol NVLNF).
Also see all insider trading activities at Novelion Therapeutics Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2010 | QLTI | 500 | $2,855 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2010-05-07 | QLTI | Buy | 500 | 5.71 | 2,855 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Panigrahi Dipak (SVP, R&D and CMO of Novelion Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.